• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ActivMed opens N.H. research center

ActivMed opens N.H. research center

August 17, 2010
CenterWatch Staff

ActivMed Practices & Research, which runs a clinical research center in Northern Massachusetts, has opened a second site in Rochester, N.H., a city where patient access to clinical trials could help raise the level of healthcare in the community by offering higher standards of treatment and access to cutting-edge therapies.

When ActivMed looked at the demographics of the population in Rochester, CEO and President Terry Stubbs decided it was a good area to develop for clinical research. The community, which has one of the lowest per capita incomes in New Hampshire and an unemployment rate higher than the state average, has a large percentage of underserved patients who want access to health treatments. “It’s a blue-collar population. There are a lot of people who have lost their insurance because they have lost their jobs or are self-employed doing clamming or chopping wood to make ends meet,” said Stubbs, who has managed more than 300 clinical trials and has more than 22 years of healthcare management experience. “We believe recruitment will do well because we can offer services to people that they normally wouldn’t get. We figured it might be a good place to run clinical trials and help people get more healthcare.”

When ActivMed’s new center opened Aug. 9, it had already begun recruiting and screening patients for a two-year chronic obstructive pulmonary disease (COPD) trial that does not include a placebo, which means all patients will receive an active drug. The new center also is awaiting word on seven other clinical trial applications still pending.

In addition to the large patient pool, Stubbs also found physicians in Rochester eager to participate in clinical research. “One of the physicians who has a family practice there was very interested in helping us to expand. Physicians he knows also are jumping on board, so it all seemed to fall into place,” she said.

Six physicians who specialize in family practice, anesthesiology and pain have agreed to conduct clinical studies from the site, and ActivMed has hired two staff members for the center. The 900-square-foot research site includes two exam rooms, a waiting area, laboratory space, and monitor and office areas. In addition, the research center is behind an independent pharmacy, where the site will be able to post clinical trial recruitment information.

ActivMed’s two sites, which are about 50 miles apart, will share regulatory services based in its Haverhill, Mass., office. In addition, ActivMed has a full-time recruiter who will be responsible for both offices.

ActivMed offers a multi-specialty network of research physicians and psychiatrists and participates in phase I, II, III, IIIB and IV clinical trials on an inpatient and outpatient basis. The company has a database of more than 250,000 patients. Although ActivMed doesn’t have immediate plans to open additional sites, Stubbs said the company has begun to explore the possibility of running an international site. “But that’s in the future,” she said.

—Karyn Korieth

Upcoming Events

  • 12Apr

    The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing